Replacement of mycophenolate acid with everolimus in patients who became neutropenic after renal transplant

Neutropenia after kidney transplant is an adverse event usually treated with a dosage reduction of mycophenolic acid. We evaluated the efficacy and safety of substituting mycophenolic acid with everolimus in patients with persistent neutropenia after kidney transplant. This study was a retrospective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental and clinical transplantation 2014-02, Vol.12 (1), p.31-36
Hauptverfasser:	Savvidaki, Eirini, Kazakopoulos, Panagiotis, Papachristou, Evangelos, Karavias, Dimitrios, Zavvos, Vasilios, Voliotis, Georgios, Kalliakmani, Pantelitsa, Marangos, Markos, Goumenos, Dimitrios S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Cytomegalovirus Infections - drug therapy Cytomegalovirus Infections - immunology Drug Substitution Drug Therapy, Combination Everolimus Female Ganciclovir - adverse effects Ganciclovir - analogs & derivatives Graft Rejection - immunology Graft Rejection - prevention & control Graft Survival - drug effects Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Kidney Transplantation - adverse effects Male Middle Aged Mycophenolic Acid - adverse effects Neutropenia - chemically induced Retrospective Studies Risk Factors Sirolimus - administration & dosage Sirolimus - analogs & derivatives Steroids - administration & dosage Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!